• The Urgent Search for a Vaccine

    Market Watch by on April 15th, 2016

    The recent outbreak of the Zika virus in South America—which began in Brazil in May 2015 and has now spread to over 30 countries—has raised fears around the globe, as public health officials believe the viral infection threatens the health of both pregnant women and their unborn children. The origin and current epicenter of the […]

  • How Innovation is Revolutionizing Vasculitis Treatment

    Market Watch by on January 18th, 2016

    The vasculitis treatment market is expected to change drastically by 2024 in the seven major pharmaceutical markets (7MM: U.S., France, Germany, Spain, Italy, UK, and Japan) with the anticipated launch of five biologics that are priced at a premium to the existing therapies. Besides Nucala, all biologics have the potential for label expansion to other […]

  • Unmet Needs Expand Bone Graft Substitutes Market

    Market Watch by and on September 16th, 2015

    The incidence of bone fractures is steadily increasing in the U.S. due to the rapidly aging population and the corresponding increase in the prevalence of associated conditions, such as osteoporosis. Although autologous bone grafts and bone allografts have proven to be effective during surgical procedures employed in the treatment of localized bone damage, limited availability […]

  • A Robust Market Rich with Opportunities: Advanced Wound Dressings

    Market Watch by on June 13th, 2015

    The expansive wound care market encompasses all aspects of wound management, including wound cleansing, debridement, infection prevention, and fluid absorption and retention. As the rates of risk factors for developing chronic, difficult-to-heal wounds surge, the need for comprehensive therapies is becoming increasingly crucial. Advanced wound dressings, in particular, play an indispensable role by providing clinicians […]

  • High Growth Anticipated for the Duchenne Muscular Dystrophy (DMD) Market

    The Duchenne Muscular Dystrophy (DMD) treatment market is expected to change radically by 2019 in the six major pharmaceutical markets (6MM: The U.S., France, Germany, Italy, Spain and the UK), with the potential launch of mutation-specific therapies with orphan drug status, high-price points and market exclusivities. The current lack of efficacious therapies and a strong […]

  • The Influence of Emerging Stakeholders on Prescribing and Treatment Decisions

    Market Watch by on October 24th, 2014

    As the healthcare industry has experienced growing pressure to adopt a focus on care quality and health outcomes while reducing costs, traditional delivery and payment models continue giving way to new approaches. Practices are merging, hospitals are consolidating and for some stakeholders, pay-for-performance is replacing fee-for-service. Payers are collaborating with integrated hospital systems and physician […]

  • Mobile Micromarketing: Driving Performance From Strategy Through Execution

    Market Watch by on August 17th, 2014

    To surmount marketplace challenges, many life sciences manufacturers have created new commercial models built on account-based selling, customer-centric selling and multi-channel marketing. Yet innovative as these strategies may be, most organizations have not fully prepared or equipped the sales force to execute them. The result is a gap between strategy and execution that impedes brand […]

  • Developing a Long-Term Master Data Management Strategy

    Market Watch by and on June 16th, 2014

    Today’s life sciences companies often find themselves in an unfortunate situation when it comes to their systems for managing master data—they’ve allowed spot solutions to proliferate, function by function, only to have integration issues later on. However, with proper forethought and careful planning, they can ensure that their Master Data Management (MDM) solutions solve their […]

  • How Does The ACA Impact My Product in 2014?

    Market Watch by on April 16th, 2014

    For much of 2013, clients asked what to expect from the Affordable Care Act (ACA). Our answer has been, “it will depend.” For some brands, in some geographies, newly insured patients will increase unit sales. However, the ACA is no “Part D, Part Deux,” in which, 2006 witnessed a rising tide of patients who did […]

  • Flipping the Model: Making Marketing Move Further, Faster in a New Technology Era

    Market Watch by on February 8th, 2014

    As life sciences companies look to differentiate themselves in an increasingly competitive market, a new technology landscape is emerging. Brand teams are voicing new requirements based on their vision of what “good” marketing looks like today. Technology must enable the execution of marketing campaigns that deliver optimal messaging to a wide array of healthcare stakeholders […]

  • Personalizing the Customer Experience

    Market Watch by and on December 10th, 2013

    Brand teams that wish to create a personalized experience for the customer via multi-channel and closed-loop marketing must be able to track relationships and behavior using master data for an individual or entity across an entire organization. However, marketers are sometimes working with insufficient data and not aware of the impact of quality data on […]

  • Dealing with Adverse Events in Social Media

    Market Watch by on October 23rd, 2013

    More than 20% of online conversations are health related. While the percentage of online conversations involving health may be high, this presents a unique challenge to health marketers in the social media space. Content in social media tends to be consumer driven and spontaneous in nature, a strong contrast to the control of the traditional […]

  • Developing a Data Acquisition Strategy for Your Specialty Brand

    Market Watch by and on August 8th, 2013

    Information collection for tracking specialty product distribution in the U.S. has become highly fragmented, with a growing universe of 670 specialty pharmacy provider (SPPs) locations ranging from large, national SPPs to boutique pharmacy networks and local SPPs. Other sources of market information include syndicated data providers, wholesalers, patient management hubs, group purchasing organizations, and large […]

Back to top